Combining perfluorocarbon and superparamagnetic iron‐oxide cell labeling for improved and expanded applications of cellular MRI

The ability to detect the migration of cells in living organisms is fundamental in understanding biological processes and important for the development of novel cell‐based therapies to treat disease. MRI can be used to detect the migration of cells labeled with superparamagnetic iron‐oxide (SPIO) or perfluorocarbon (PFC) agents. In this study, we explored combining these two cell‐labeling approaches to overcome current limitations and enable new applications for cellular MRI.

[1]  M. Stuber,et al.  Magnetic Resonance Imaging Overestimates Ferumoxide-Labeled Stem Cell Survival After Transplantation in the Heart , 2008, Circulation.

[2]  Peter C M van Zijl,et al.  MR tracking of transplanted cells with “positive contrast” using manganese oxide nanoparticles , 2008, Magnetic resonance in medicine.

[3]  E. Purcell,et al.  Effects of Diffusion on Free Precession in Nuclear Magnetic Resonance Experiments , 1954 .

[4]  S. Caruthers,et al.  19F magnetic resonance imaging for stem/progenitor cell tracking with multiple unique perfluorocarbon nanobeacons , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[5]  Eric T Ahrens,et al.  In vivo imaging platform for tracking immunotherapeutic cells , 2005, Nature Biotechnology.

[6]  P. Ricciardi-Castagnoli,et al.  Establishment of a cell line with features of early dendritic cell precursors from fetal mouse skin , 1995, European journal of immunology.

[7]  Haosen Zhang,et al.  Other Non-Stem Cell Therapies for Cellular Tracking—Inflammatory Cell Tracking , 2011 .

[8]  Donald S. Williams,et al.  Detection of single mammalian cells by high-resolution magnetic resonance imaging. , 1999, Biophysical journal.

[9]  Kathryn Sharer,et al.  In vivo detection of single cells by MRI , 2006, Magnetic resonance in medicine.

[10]  F. Yeh,et al.  Decreased reticuloendothelial system clearance and increased blood half-life and immune cell labeling for nano- and micron-sized superparamagnetic iron-oxide particles upon pre-treatment with Intralipid. , 2013, Biochimica et biophysica acta.

[11]  B. Rutt,et al.  Rapid combined T1 and T2 mapping using gradient recalled acquisition in the steady state , 2003, Magnetic resonance in medicine.

[12]  Yin Zhang,et al.  Non-invasive imaging of human embryonic stem cells. , 2010, Current pharmaceutical biotechnology.

[13]  Olivier Tillement,et al.  High-resolution cellular MRI: gadolinium and iron oxide nanoparticles for in-depth dual-cell imaging of engineered tissue constructs. , 2013, ACS nano.

[14]  S. Meiboom,et al.  Modified Spin‐Echo Method for Measuring Nuclear Relaxation Times , 1958 .

[15]  Haosen Zhang,et al.  A New Nano-sized Iron Oxide Particle with High Sensitivity for Cellular Magnetic Resonance Imaging , 2011, Molecular Imaging and Biology.

[16]  Alan P Koretsky,et al.  Highly efficient endosomal labeling of progenitor and stem cells with large magnetic particles allows magnetic resonance imaging of single cells. , 2003, Blood.

[17]  N. Noginova,et al.  Effects of magnetic nanoparticles on nuclear spin relaxation in viscous systems , 2011 .

[18]  H. Youn,et al.  In Vivo Non Invasive Molecular Imaging for Immune Cell Tracking in Small Animals , 2012, Immune network.

[19]  J. Bulte,et al.  Feasibility of concurrent dual contrast enhancement using CEST contrast agents and superparamagnetic iron oxide particles , 2009, Magnetic resonance in medicine.

[20]  P. Jacobs,et al.  Physical and chemical properties of superparamagnetic iron oxide MR contrast agents: ferumoxides, ferumoxtran, ferumoxsil. , 1995, Magnetic resonance imaging.

[21]  E T Ahrens,et al.  Receptor‐mediated endocytosis of iron‐oxide particles provides efficient labeling of dendritic cells for in vivo MR imaging , 2003, Magnetic resonance in medicine.

[22]  T. Hitchens,et al.  A non-invasive approach to detecting organ rejection by MRI: monitoring the accumulation of immune cells at the transplanted organ. , 2004, Current pharmaceutical biotechnology.

[23]  P M Jakob,et al.  Application of compressed sensing to in vivo 3D ¹⁹F CSI. , 2010, Journal of magnetic resonance.

[24]  E. Terreno,et al.  In vivo MRI visualization of different cell populations labeled with PARACEST agents , 2013, Magnetic resonance in medicine.

[25]  E. Ahrens,et al.  In vivo MRI cell tracking using perfluorocarbon probes and fluorine‐19 detection , 2013, NMR in biomedicine.

[26]  Qing Ye,et al.  In situ labeling of immune cells with iron oxide particles: an approach to detect organ rejection by cellular MRI. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[27]  Qing Ye,et al.  19F MRI detection of acute allograft rejection with in vivo perfluorocarbon labeling of immune cells , 2011, Magnetic resonance in medicine.

[28]  E. Ahrens,et al.  Fluorine-containing nanoemulsions for MRI cell tracking. , 2009, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.

[29]  A. G. Gittenberger-de Groot,et al.  Cell tracking using iron oxide fails to distinguish dead from living transplanted cells in the infarcted heart , 2010, Magnetic resonance in medicine.

[30]  Mangala Srinivas,et al.  Fluorine‐19 MRI for visualization and quantification of cell migration in a diabetes model , 2007, Magnetic resonance in medicine.

[31]  J. Bulte,et al.  Tracking immune cells in vivo using magnetic resonance imaging , 2013, Nature Reviews Immunology.